Breast Ductal Carcinoma

69 relevant articles (0 outcomes, 12 trials/studies) found for this Disease

Description: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.

Also Known As:

Carcinoma, Ductal, Breast; Carcinoma, Invasive Ductal, Breast; Carcinoma, Mammary Ductal; Invasive Ductal Carcinoma, Breast; Mammary Ductal Carcinoma; Carcinomas, Infiltrating Duct; Carcinomas, Mammary Ductal; Mammary Ductal Carcinomas; Carcinoma, Infiltrating Duct

Subscribe to New Research on Breast Ductal Carcinoma

Disease Context: Research Results

Neoplasms: 379784

Neoplasms by Histologic Type: 1

Glandular and Epithelial Neoplasms: 237

Carcinoma: 88278

Adenocarcinoma: 25413

Ductal Carcinoma: 1052

Breast Ductal Carcinoma: 69

Neoplasms, Ductal, Lobular, and Medullary

Ductal Carcinoma: 1052

Breast Ductal Carcinoma: 69

Neoplasms by Site: 1

Breast Neoplasms: 59104

Breast Ductal Carcinoma: 69

Skin and Connective Tissue Diseases

Skin Diseases: 5861

Breast Diseases: 918

Breast Neoplasms: 59104

Breast Ductal Carcinoma: 69

Related Diseases

1.	Noninfiltrating Intraductal Carcinoma (DCIS)
2.	Breast Neoplasms (Breast Cancer)
3.	Carcinoma (Carcinomatosis)
4.	Ductal Carcinoma
5.	Prostatic Intraepithelial Neoplasia
25 Diseases and 33 more articles analyzed in the Research Interface, order at left...

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Breast Ductal Carcinoma:

1.	Estrogens (Estrogen)FDA Link 01/01/2001 - "Prognostic value of immunocytochemical estimation of estrogen receptor (ER) and of pS2 estrogen-dependent protein in cells of mammary ductal carcinoma" 01/01/2001 - "Analysis of estrogen receptor (ER) and estrogen-dependent pS2 protein expression in cells of mammary ductal carcinoma." 09/01/1987 - "A-ring substituted estrogens as inhibitors of the MXT transplantable mammary ductal carcinoma." 01/01/2005 - "BACKGROUND: Our previous studies revealed that a subset of mammary ductal carcinoma in situ (DCIS) contained focally disrupted myoepithelial (ME) cell layers that were predominantly overlain by estrogen receptor (ER) negative cells, which showed a substantially higher rate of cell proliferation and genetic alterations than adjacent ER positive cells within the same duct" 05/01/2002 - "p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas." Get all the results and reference details, order at left...
2.	Messenger RNA (mRNA)IBA 07/01/2005 - "This study compares the expression of COX-2 mRNA and protein in breast ductal carcinoma relative to non-tumour breast tissue" 04/01/2005 - "BACKGROUND: Our previous studies revealed that the mRNA encoded by BP1, a member of the homeobox gene superfamily of transcription factors, was expressed in leukemia and infiltrating breast ductal carcinoma (IDC)" Get all the results and reference details, order at left...
3.	Captopril (Capoten)FDA LinkGeneric 06/01/1999 - "The present study evaluated the mechanism of captopril's antiproliferative action in an ER/PR-negative human mammary ductal carcinoma cell line, Hs578T" 06/01/1999 - "We have previously demonstrated that human mammary ductal carcinoma cells are among the cell types whose mitotic activity is inhibited by captopril" 06/01/1999 - "Mechanism of captopril toxicity to a human mammary ductal carcinoma cell line in the presence of copper." 07/01/1997 - "Captopril modulates hormone receptor concentration and inhibits proliferation of human mammary ductal carcinoma cells in culture." 07/01/1997 - "The present study evaluated the effect of the angiotensin converting enzyme (ACE) inhibitor captopril on estrogen (ER) and progesterone (PR) receptor concentration and on proliferation in two lines of human mammary ductal carcinoma cells in culture: T-47D (ER+/PR+) and Hs578T (ER-/PR-)" Get all the results and reference details, order at left...
4.	DNA (Deoxyribonucleic Acid)IBA 09/01/2000 - "This study estimated nuclear DNA ploidy and DNA proliferative indices (PI) in mammary ductal carcinomas from 120 Iraqi female patients" 10/01/2005 - "DNA hypermethylation of TIMP3 gene in invasive breast ductal carcinoma." 08/01/1993 - "Several reports have suggested that HPV genital infections are multifocal; however, HPV DNA was also found in the lymph nodes and in the granulocytes of women with cervical cancer, in ovarian and endometrial tissue, in tumours of the urinary bladder, and in mammary ductal carcinoma." Get all the results and reference details, order at left...
5.	Protein Kinase C-alphaIBA 10/01/2004 - "Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinoma." 10/01/2004 - "The purpose of this study was to determine if Protein Kinase C alpha (PKC alpha) is altered in expression or localisation in normal breast, ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC)" Get all the results and reference details, order at left...
6.	Steryl-Sulfatase (Steroid Sulfatase)IBA 01/01/1985 - "Two estrogen sulfatases, arylsulfatase C-estrone sulfatase (ASC-ES) and d-equilenin sulfatase (EqS) were demonstrated histochemically in the normal human female breast, in benign breast diseases and in infiltrating mammary ductal carcinomas to study their significance in the pathogenesis of epithelial proliferations" Get all the results and reference details, order at left...
7.	TIE-2 Receptor (Receptor, TIE 2)IBA 01/01/2007 - "The current study sought to examine the levels of the expression of Ang-1, Ang-2, Ang-3 and their receptor Tie-2 in mammary ductal carcinoma and to assess their relevance to prognosis" Get all the results and reference details, order at left...
8.	Finasteride (Propecia)FDA LinkGeneric 01/01/1997 - "Over 40 short-term clinical trials are in progress, testing the following classes of agents on precancerous lesions in the different major organ systems: antimutagens (N-acetylcysteine, oltipraz), antiproliferatives (difluoromethylornithine, dehydroepiandrosterone, selenomethionine), antioxidants (vitamin E, curcumin), anti-inflammatories (aspirin, piroxicam, ibuprofen, sulindac sulfone) and hormonally active agents (tamoxifen in breast ductal carcinoma in situ and finasteride in prostatic intraepithelial neoplasia)" Get all the results and reference details, order at left...
9.	Antimutagenic Agents (Antimutagens)IBA 01/01/1997 - "Over 40 short-term clinical trials are in progress, testing the following classes of agents on precancerous lesions in the different major organ systems: antimutagens (N-acetylcysteine, oltipraz), antiproliferatives (difluoromethylornithine, dehydroepiandrosterone, selenomethionine), antioxidants (vitamin E, curcumin), anti-inflammatories (aspirin, piroxicam, ibuprofen, sulindac sulfone) and hormonally active agents (tamoxifen in breast ductal carcinoma in situ and finasteride in prostatic intraepithelial neoplasia)" Get all the results and reference details, order at left...
10.	Cadherins (E-Cadherin)IBA 07/01/2007 - "In this study, the expression of E-cadherin was examined in mammary ductal carcinoma in situ, invasive breast carcinomas without metastasis, invasive carcinomas with their lymph node and distant metastases and invasive carcinomas with local recurrence in breast cancer tissue" Get all the results and reference details, order at left...
89 Drugs and Important Bio-Agents and 63 more articles analyzed in the Research Interface, order at left...

Therapies and Procedures

1.	Mastectomy (Mammectomy) 10/25/2002 - "METHODS: The author reviewed the histologic slides from all 556 patients who underwent wide excision/mastectomy for mammary ductal carcinoma, either in situ or invasive, at Pamela Youde Nethersole Eastern Hospital, Hong Kong, during an 8-year period from early 1994 to the end of 2001" 11/01/2003 - "CASES: Two cases of pure mammary mucinous carcinoma occurred with marked cytoplasmic hyalinization among 556 wide excision/mastectomy specimens of mammary ductal carcinoma, either in situ or invasive, encountered at Pamela Youde Nethersole Eastern Hospital, Hong Kong, during the period from 1994 to the end of 2001" 11/01/2004 - "CONCLUSION: The skin sparing mastectomy and immediate autograft tissue breast reconstruction is an ideal reconstructive method for the patients with breast ductal carcinoma in situ or huge breast carcinoid in condition that there were strict operative indication and relapse can be prevented." 12/01/1999 - "In addition, one of the patients also underwent mastectomy with axillary dissection and radiotherapy for a left breast ductal carcinoma and subsequently developed multiple squamous carcinomas and intraepithelial carcinomas on the left upper limb" Get all the results and reference details, order at left...
2.	Mammaplasty (Breast Reconstruction) 11/01/2004 - "CONCLUSION: The skin sparing mastectomy and immediate autograft tissue breast reconstruction is an ideal reconstructive method for the patients with breast ductal carcinoma in situ or huge breast carcinoid in condition that there were strict operative indication and relapse can be prevented." Get all the results and reference details, order at left...
3.	Modified Radical Mastectomy (Mastectomy, Modified) 06/01/1997 - "Tubular carcinoma is a distinctive subtype of invasive, well-differentiated mammary ductal carcinoma that has a good prognosis when treated by modified radical mastectomy" Get all the results and reference details, order at left...
4.	Autologous Transplantation (Autograft) 11/01/2004 - "CONCLUSION: The skin sparing mastectomy and immediate autograft tissue breast reconstruction is an ideal reconstructive method for the patients with breast ductal carcinoma in situ or huge breast carcinoid in condition that there were strict operative indication and relapse can be prevented." Get all the results and reference details, order at left...
5.	Transplantation (Transplant Recipients) 06/01/2003 - "Using medroxyprogesterone acetate (MPA) as a carcinogen, we were able to induce in BALB/c female mice, several progestin-dependent mammary ductal carcinomas that regress completely with estrogen or antiprogestins and are maintained by serial transplantations in syngeneic mice" Get all the results and reference details, order at left...
6 Therapies and Procedures and 7 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>